Development of cell-expressed and virion-incorporated CCR5-targeted vaccine

Biochemical and Biophysical Research Communications

Volumn 377, Issue 2, 2008, Pages 617-621

  Misumi, Shogo ^a   Eto, Ayumi ^a   Mitsumata, Ryotarou ^a   Yamada, Masanori ^a   Takamune, Nobutoki ^a   Shoji, Shozo ^a,b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO HEALTH SCIENCE UNIVERSITY   (Japan)

Author keywords

Cell expressed CCR5; Cycloimmunogen; SIVmac239; Virion incorporated CCR5

Indexed keywords

ANTISERUM; CHEMOKINE RECEPTOR CCR5; KEYHOLE LIMPET HEMOCYANIN; PEPTIDE DERIVATIVE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRION; VIRUS PARTICLE; VIRUS REACTIVATION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; EPITOPES, B-LYMPHOCYTE; HIV; HUMANS; MICE; MICE, INBRED BALB C; PEPTIDES; RECEPTORS, CCR5; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL VACCINES; VIRION;

SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 55549113991     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.022     Document Type: Article

References (26)

1. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., and O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273 (1996) 1856-1862
2. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., and Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381 (1996) 661-666
3. Barassi C., Lazzarin A., and Lopalco L. CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. Blood 104 (2004) 2205-2206
4. Misumi S., Nakajima R., Takamune N., and Shoji S. A cyclic dodecapeptide-multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg(168) to Cys(178)) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine. J. Virol. 75 (2001) 11614-11620
5. Misumi S., Nakayama D., Kusaba M., Iiboshi T., Mukai R., Tachibana K., Nakasone T., Umeda M., Shibata H., Endo M., Takamune N., and Shoji S. Effects of immunization with CCR5-based cycloimmunogen on simian/HIVSF162P3 challenge. J. Immunol. 176 (2006) 463-471
6. Chackerian B., Lowy D.R., and Schiller J.T. Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles. Proc. Natl. Acad. Sci. USA 96 (1999) 2373-2378
7. Chackerian B., Briglio L., Albert P.S., Lowy D.R., and Schiller J.T. Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus. J. Virol. 78 (2004) 4037-4047
8. Lehner T., Doyle C., Wang Y., Babaahmady K., Whittall T., Tao L., Bergmeier L., and Kelly C. Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity. J. Immunol. 166 (2001) 7446-7455
9. Monde K., Maeda Y., Tanaka Y., Harada S., and Yusa K. Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5. J. Biol. Chem. 282 (2007) 36923-36932
10. Ott D.E. Potential roles of cellular proteins in HIV-1. Rev. Med. Virol. 12 (2002) 359-374
11. Tremblay M.J., Fortin J.F., and Cantin R. The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today 19 (1998) 346-351
12. Ott D.E. Cellular proteins in HIV virions. Rev. Med. Virol. 7 (1997) 167-180
13. Lallos L.B., Laal S., Hoxie J.A., Zolla-Pazner S., and Bandres J.C. Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope. AIDS Res. Hum. Retroviruses 15 (1999) 895-897
14. Akari H., Fukumori T., Iida S., and Adachi A. Induction of apoptosis in herpesvirus saimiri-immortalized T lymphocytes by blocking interaction of CD28 with CD80/CD86. Biochem. Biophys. Res. Commun. 263 (1999) 352-356
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
16. Gosling J., Monteclaro F.S., Atchison R.E., Arai H., Tsou C.L., Goldsmith M.A., and Charo I.F. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94 (1997) 5061-5066
17. Siciliano S.J., Kuhmann S.E., Weng Y., Madani N., Springer M.S., Lineberger J.E., Danzeisen R., Miller M.D., Kavanaugh M.P., DeMartino J.A., and Kabat D. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. J. Biol. Chem. 274 (1999) 1905-1913
18. Gibellini D., Vitone F., Gori E., La Placa M., and Re M.C. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients. J. Virol. Methods 115 (2004) 183-189
19. Ui M., Kuwata T., Igarashi T., Ibuki K., Miyazaki Y., Kozyrev I.L., Enose Y., Shimada T., Uesaka H., Yamamoto H., Miura T., and Hayami M. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs. Virology 265 (1999) 252-263
20. Farzan M., Mirzabekov T., Kolchinsky P., Wyatt R., Cayabyab M., Gerard N.P., Gerard C., Sodroski J., and Choe H. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96 (1999) 667-676
21. 2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J. Exp. Med. 194 (2001) 1661-1673
22. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., and Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 (1996) 367-377
23. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., and Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 (1996) 722-725
24. Pastori C., Weiser B., Barassi C., Uberti-Foppa C., Ghezzi S., Longhi R., Calori G., Burger H., Kemal K., Poli G., Lazzarin A., and Lopalco L. Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression. Blood 107 (2006) 4825-4833
25. Klasse P.J., and Sattentau Q.J. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 83 (2002) 2091-2108
26. Parren P.W., and Burton D.R. The antiviral activity of antibodies in vitro and in vivo. Adv. Immunol. 77 (2001) 195-262